Hypothermic machine perfusion for liver graft preservation

A recent review article by Amin et al. focused on the mechanistic actions of hypothermic machine perfusion (HMP) in liver graft preservation, the clinical literature of HMP in liver transplantation and the future directions of clinical application of HMP in liver transplantation.

They highlighted the following key points:

Due to its ability to provide oxygen and nutrients and remove toxic metabolic waste products, HMP leads to less severe ischemic reperfusion injury
Current clinical evidence has shown that HMP provides decreased biliary complications and lower early allograft dysfunction (EAD) rates which leads to increased liver graft survival
Recent studies looking at viability assessment during HMP show promising results, such as those analyzing flavin mononucleotide (FMN)

Overall, they concluded that HMP for liver graft preservation has the potential to increase the number of liver transplants and improve results with livers from donors after circulatory death (DCD) and extended criteria donors after brain death (DBD).

Read the full article here: https://journals.lww.com/co-transplantation/Citation/2022/04000/Hypothermic_machine_perfusion_for_liver_graft.3.aspx

Tagged In:

DCD, EAD, ECD, HMP, Liver

The Latest

Check out the most recent posts

Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model

Clinical Evidence

In a pre-clinical study using a porcine DCD model, Panayotova et al. sought to validate the novel technique of oxygen “pre-charge” for hypothermic machine perfusion (HMP) using the LifePort Liver Transporter. The study evaluated the effects of this preservation method...

David’s Transplant Journey

News

In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...

Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era

Clinical Evidence

A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...

Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?

Clinical Evidence

In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...